Literature DB >> 7832637

Concentration and distribution of infectivity and PrPSc following partial denaturation of a mouse-adapted and a hamster-adapted scrapie strain.

R Rubenstein1, R I Carp, W Ju, C Scalici, M Papini, A Rubenstein, R Kascsak.   

Abstract

PrPSc is a specific protein marker for slow infectious diseases known as the transmissible subacute spongiform encephalopathies. Although PrPSc is closely associated with infectivity, it is not known if it is the infectious agent itself, a component of the agent or merely adventitiously associated with infectivity. In the present study we demonstrate that the resistance of PrPSc to partial denaturation and of infectivity to inactivation differs markedly for two scrapie strains. Proteinase K treatment or electrophoretic analysis of partially denatured PrPSc preparations reveal a dissociation between infectivity and demonstrable PrPSc. Our findings support other evidence that not all PrPSc is required for infectivity. Our studies combined with previous biological analyses suggest that PrPSc cannot be the sole component associated with the infectious agent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7832637     DOI: 10.1007/bf01310793

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains.

Authors:  R J Kascsak; R Rubenstein; P A Merz; R I Carp; N K Robakis; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

2.  The puzzle of PrPSc and infectivity--do the pieces fit?

Authors:  R I Carp; R J Kascsak; R Rubenstein; P A Merz
Journal:  Trends Neurosci       Date:  1994-04       Impact factor: 13.837

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Purification and structural studies of a major scrapie prion protein.

Authors:  S B Prusiner; D F Groth; D C Bolton; S B Kent; L E Hood
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

5.  Further purification and characterization of scrapie prions.

Authors:  S B Prusiner; D C Bolton; D F Groth; K A Bowman; S P Cochran; M P McKinley
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

6.  The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice.

Authors:  R H Kimberlin; C A Walker; H Fraser
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

7.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

8.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

9.  Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation.

Authors:  Y G Xi; L Ingrosso; A Ladogana; C Masullo; M Pocchiari
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

10.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  6 in total

1.  Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange.

Authors:  Vytautas Smirnovas; Jae-Il Kim; Xiaojun Lu; Ryuichiro Atarashi; Byron Caughey; Witold K Surewicz
Journal:  J Biol Chem       Date:  2009-07-13       Impact factor: 5.157

2.  Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors.

Authors:  Jae-Il Kim; Ignazio Cali; Krystyna Surewicz; Qingzhong Kong; Gregory J Raymond; Ryuichiro Atarashi; Brent Race; Liuting Qing; Pierluigi Gambetti; Byron Caughey; Witold K Surewicz
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

3.  PrP antibody binding-induced epitope modulation evokes immunocooperativity.

Authors:  Binggong Chang; Michael W Miller; Marie S Bulgin; Sharon Sorenson-Melson; Aru Balachandran; Allen Chiu; Richard Rubenstein
Journal:  J Neuroimmunol       Date:  2008-10-31       Impact factor: 3.478

4.  Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice.

Authors:  Daryl S Spinner; In Soo Cho; Seung Yong Park; Jae Il Kim; Harry C Meeker; Xuemin Ye; Giuseppe Lafauci; Daniel J Kerr; Michael J Flory; Bo Sook Kim; Regina B Kascsak; Thomas Wisniewski; William R Levis; Georgia B Schuller-Levis; Richard I Carp; Eunkyue Park; Richard J Kascsak
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

5.  The association between PrP and infectivity in scrapie and BSE infected mouse brain.

Authors:  R A Somerville; A J Dunn
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Thermostability as a highly dependent prion strain feature.

Authors:  Alba Marín-Moreno; Patricia Aguilar-Calvo; Mohammed Moudjou; Juan Carlos Espinosa; Vincent Béringue; Juan María Torres
Journal:  Sci Rep       Date:  2019-08-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.